Treatment of atherosclerosis with MgNa.sub.2 EDTA

Details Treatment of atherosclerosis with MgNa.sub.2 EDTA Treatment of atherosclerosis with MgNa.sub.2 EDTA

1991-01-30

1992-05-19

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 31195

Patent

active

051149745

ABSTRACT:
The treatment of atherosclerosis by administration of pure MgNa.sub.2 EDTA to a patient to favorably influence one or more of the multiple stages in the complex pathophysiology of the disease.

REFERENCES:
patent: 2193717 (1940-03-01), Faust et al.
patent: 2781291 (1957-02-01), Rubin et al.
patent: 2846317 (1958-08-01), Bersworth et al.
Weiss, G. B., Drug Dev. Res. 6(2): 135-139 1985.
Bloom, S., Magnesium 5(3-4): 154-164 1986.
Des Prez, R. M. et al, Thromb Diath Haemorph 17(3-4): 516-531 1967.
Lowenhaupt, R. W. et al, J Lab Clin Med 90(1): 37-45 1977.
Orimo, H. et al, Ann NY Acad Sci 598: 444-457 1990.
Sloth-Nielsen, J. et al., Am J Surg 162 (1991); 122-125.
Proc Soc Exptl Biol and Med 103 663 (1960).
Bull Georgetown Univ Med Center 1, 33 (1951).

Affiliated with

Also associated with

Rating

Treatment of atherosclerosis with MgNa.sub.2 EDTA does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of atherosclerosis with MgNa.sub.2 EDTA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of atherosclerosis with MgNa.sub.2 EDTA will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2417726